Pacific Biosciences Of California Total Current Assets 2010-2024 | PACB

Pacific Biosciences Of California total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Pacific Biosciences Of California Annual Total Current Assets
(Millions of US $)
2023 $742
2022 $852
2021 $1,101
2020 $356
2019 $81
2018 $132
2017 $102
2016 $109
2015 $111
2014 $118
2013 $126
2012 $115
2011 $200
2010 $293
2009 $94
Pacific Biosciences Of California Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $628
2024-03-31 $677
2023-12-31 $742
2023-09-30 $882
2023-06-30 $936
2023-03-31 $981
2022-12-31 $852
2022-09-30 $914
2022-06-30 $970
2022-03-31 $1,029
2021-12-31 $1,101
2021-09-30 $1,130
2021-06-30 $1,189
2021-03-31 $1,196
2020-12-31 $356
2020-09-30 $240
2020-06-30 $151
2020-03-31 $170
2019-12-31 $81
2019-09-30 $77
2019-06-30 $99
2019-03-31 $113
2018-12-31 $132
2018-09-30 $144
2018-06-30 $96
2018-03-31 $116
2017-12-31 $102
2017-09-30 $114
2017-06-30 $133
2017-03-31 $88
2016-12-31 $109
2016-09-30 $122
2016-06-30 $138
2016-03-31 $119
2015-12-31 $111
2015-09-30 $86
2015-06-30 $90
2015-03-31 $100
2014-12-31 $118
2014-09-30 $114
2014-06-30 $120
2014-03-31 $132
2013-12-31 $126
2013-09-30 $142
2013-06-30 $122
2013-03-31 $126
2012-12-31 $115
2012-09-30 $132
2012-06-30 $153
2012-03-31 $177
2011-12-31 $200
2011-09-30 $220
2011-06-30 $245
2011-03-31 $264
2010-12-31 $293
2010-09-30 $117
2010-06-30
2010-03-31
2009-12-31
2009-09-30
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.670B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.197B 25.52
Intuitive Surgical (ISRG) United States $190.823B 99.77
Alcon (ALC) Switzerland $45.517B 32.04
IQVIA Holdings (IQV) United States $39.384B 21.70
Edwards Lifesciences (EW) United States $39.340B 24.98
IDEXX Laboratories (IDXX) United States $35.808B 42.17
DexCom (DXCM) United States $27.463B 41.36
Waters (WAT) United States $22.607B 33.43
SONOVA HOLDING (SONVY) Switzerland $22.062B 0.00
STERIS (STE) Ireland $21.899B 25.21
Hologic (HOLX) United States $18.440B 19.46
Sysmex ADR (SSMXY) Japan $12.915B 40.50
Fresenius Medical Care AG KGaA (FMS) Germany $12.552B 12.89
Globus Medical (GMED) United States $11.102B 28.27
Penumbra (PEN) United States $9.290B 91.00
Teleflex (TFX) United States $9.197B 14.67
Masimo (MASI) United States $8.654B 41.87
Glaukos (GKOS) United States $7.887B 0.00
PROCEPT BioRobotics (PRCT) United States $5.083B 0.00
Integer Holdings (ITGR) United States $4.679B 26.52
Inari Medical (NARI) United States $3.123B 0.00
Veracyte (VCYT) United States $3.014B 90.44
TransMedics (TMDX) United States $2.991B 94.80
LivaNova (LIVN) United Kingdom $2.813B 16.24
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Elekta AB (EKTAY) Sweden $2.304B 18.77
Tandem Diabetes Care (TNDM) United States $2.060B 0.00
Integra LifeSciences Holdings (IART) United States $1.964B 10.26
RxSight (RXST) United States $1.867B 0.00
Alphatec Holdings (ATEC) United States $1.375B 0.00
Artivion (AORT) United States $1.210B 80.19
Pulse Biosciences (PLSE) United States $1.155B 0.00
OPKO Health (OPK) United States $1.072B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.951B 16.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.764B 0.00
IRadimed (IRMD) United States $0.727B 39.28
SiBone (SIBN) United States $0.664B 0.00
Mesa Laboratories (MLAB) United States $0.646B 15.23
Paragon 28 (FNA) United States $0.637B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.516B 0.00
CVRx (CVRX) United States $0.384B 0.00
Tactile Systems Technology (TCMD) United States $0.383B 20.73
Semler Scientific (SMLR) United States $0.379B 25.43
Delcath Systems (DCTH) United States $0.318B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
AngioDynamics (ANGO) United States $0.302B 0.00
Inogen (INGN) United States $0.262B 0.00
Sight Sciences (SGHT) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.213B 0.00
Atossa Genetics (ATOS) United States $0.204B 0.00
Accuray (ARAY) United States $0.199B 0.00
Nevro (NVRO) United States $0.198B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.125B 0.00
Sensus Healthcare (SRTS) United States $0.116B 17.19
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.076B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Rapid Micro Biosystems (RPID) United States $0.055B 0.00
Accelerate Diagnostics (AXDX) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Biosig Technologies (BSGM) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00